Status:
TERMINATED
Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This Study Will Evaluate Celecoxib Efficacy And Safety Versus Standard Doses Of Diclofenac In Acute Pain Due To Cervical Injury (Due To A Sprain) Related To A Motor Vehicle Accident
Detailed Description
On 21Oct2010 study was prematurely terminated due to poor enrollment with subsequent low number of participants. No safety or efficacy issues were involved in the decision to terminate prematurely.
Eligibility Criteria
Inclusion
- Patients That Had Suffered A Car Accident And Due To It Suffered A Cervical Sprain
Exclusion
- Recent Cervical Sprains Or Other Cervical Conditions
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00894790
Start Date
November 1 2009
End Date
January 1 2010
Last Update
February 2 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
México, D.F., Mexico, 04500
2
Pfizer Investigational Site
México, D.F., Mexico, 11510